# OnCo record triton3 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/triton3/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "triton3", "NCT02975934" ;
  schema:name "TRITON3"@en ;
  schema:alternateName "TRITON3"@en, "rucaparib in BRCA or ATM altered mCRPC"@en ;
  schema:description "A PARP inhibitor works for men whose prostate cancer carries a BRCA fault, and does not work for men whose fault is in ATM. Which gene is broken decides whether the drug helps."@en ;
  schema:url <https://onco.cc/trials/triton3/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02975934>, <https://doi.org/10.1056/NEJMoa2214676>, <https://www.nice.org.uk/guidance/ta887> ;
  onco:status "mixed" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:technologies <https://onco.cc/technologies/parp-inhibitor/>, <https://onco.cc/technologies/germline-testing/> ;
  onco:targets <https://onco.cc/targets/brca/>, <https://onco.cc/targets/atm/>, <https://onco.cc/targets/parp/> ;
  onco:drugs <https://onco.cc/drugs/rucaparib/> ;
  onco:companies <https://onco.cc/companies/clovis-oncology/> ;
  onco:terms <https://onco.cc/terms/hrd/>, <https://onco.cc/terms/castration-resistance/> ;
  onco:trials <https://onco.cc/trials/profound/>, <https://onco.cc/trials/propel/>, <https://onco.cc/trials/magnitude/>, <https://onco.cc/trials/talapro-2/> .